Kiniksa accounting chief sells 11,280 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc (KNSA) Chief Accounting Officer Michael R. Megna exercised options for 11,280 Class A ordinary shares at an exercise price of $17.76 per share on November 9, 2026, then sold the same number at a weighted average $98.54 per share. Both transactions were effected under a Rule 10b5-1 plan executed July 30, 2026. Following the exercise, 5,114 share options remained; the options expire August 31, 2033.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option F1, F3 | 11,280 | $0.00 | $0.00 |
| Exercise | Class A Ordinary Share F1 | 11,280 | $17.76 | $200K |
| Sale | Class A Ordinary Share F1, F2 | 11,280 | $98.54 | $1.11M |
Footnotes (3)
- F1. This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.
- F2. This transaction was executed in multiple trades through a broker-dealer at prices ranging between $98.48 and $98.64. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- F3. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted average sales price financial
vesting commencement date technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many KNSA options remained after Michael R. Megna's exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.